Plans for the California Institute of Biomedical Research

March 18, 2012

March 19, 2012 | Last week Merck announced a $90m investment in the California Institute of Biomedical Research--Calibr--to be headed by Peter Schultz. Xconomy spoke with Schultz about the hiring process, plans for collaborations, and the Institute's relationship with Merck. Xconomy